References
- GasparNHawkinsDSDirksenUEwing sarcoma: current management and future approaches through collaborationJ Clin Oncol201533273036304626304893
- JiangYLudwigJJankuFTargeted therapies for advanced Ewing sarcoma family of tumorsCancer Treat Rev201541539140025869102
- LiYJDaiYLChengYSZhangWBTuCQPositron emission tomography (18)F-fluorodeoxyglucose uptake and prognosis in patients with bone and soft tissue sarcoma: a meta-analysisEur J Surg Oncol20164281103111427189833
- MantovaniAAllavenaPSicaABalkwillFCancer-related inflammationNature2008454720343644418650914
- DiakosCICharlesKAMcMillanDCClarkeSJCancer-related inflammation and treatment effectivenessLancet Oncol20141511e493e50325281468
- AggarwalBBVijayalekshmiRVSungBTargeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foeClin Cancer Res200915242543019147746
- GuXSunSGaoXSPrognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: evidence from 3,430 patientsSci Rep201662389327025911
- KohCHBhoo-PathyNNgKLUtility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancerBr J Cancer2015113115015826022929
- LiYWangCXuMPreoperative NLR for predicting survival rate after radical resection combined with adjuvant immunotherapy with CIK and postoperative chemotherapy in gastric cancerJ Cancer Res Clin Oncol2017143586187128108815
- AltanMHaberalHBAkdoğanBÖzenHA critical prognostic analysis of neutrophil-lymphocyte ratio for patients undergoing nephroureterec-tomy due to upper urinary tract urothelial carcinomaInt J Clin Oncol Epub201769
- IshizukaMNagataHTakagiKIwasakiYShibuyaNKubotaKClinical significance of the C-reactive protein to albumin ratio for survival after surgery for colorectal cancerAnn Surg Oncol201623390090726530445
- YoudenWJIndex for rating diagnostic testsCancer195031323515405679
- LiuZJinKGuoMPrognostic value of the CRP/Alb ratio, a novel inflammation-based score in pancreatic cancerAnn Surg Oncol201724256156827650825
- CampRLDolled-FilhartMRimmDLX-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimizationClin Cancer Res200410217252725915534099
- BalkwillFMantovaniAInflammation and cancer: back to Virchow?Lancet2001357925553954511229684
- HeikkiläKEbrahimSLawlorDAA systematic review of the association between circulating concentrations of C reactive protein and cancerJ Epidemiol Community Health200761982483317699539
- Jab łońskaEKilukMMarkiewiczWPiotrowskiLGrabowskaZJabłońskiJTNF-alpha, IL-6 and their soluble receptor serum levels and secretion by neutrophils in cancer patientsArch Immunol Ther Exp (Warsz)2001491636911266093
- McCourtMWangJHSookhaiSRedmondHPActivated human neutrophils release hepatocyte growth factor/scatter factorEur J Surg Oncol200127439640311417987
- McMillanDCThe systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancerCancer Treat Rev201339553454022995477
- ShamamianPSchwartzJDPocockBJActivation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesisJ Cell Physiol2001189219720611598905
- KantolaTKlintrupKVäyrynenJPStage-dependent alterations of the serum cytokine pattern in colorectal carcinomaBr J Cancer2012107101729173623059742
- RoxburghCSMcMillanDCCancer and systemic inflammation: treat the tumour and treat the hostBr J Cancer201411061409141224548867
- Aggerholm-PedersenNMaretty-KongstadKKellerJBaerentzenSSafwatAThe prognostic value of serum biomarkers in localized bone sarcomaTransl Oncol20169432232827567955
- JiHHoughtonAMMarianiTJK-ras activation generates an inflammatory response in lung tumorsOncogene200625142105211216288213
- SwierczakAMouchemoreKAHamiltonJAAndersonRLNeutrophils: important contributors to tumor progression and metastasisCancer Metastasis Rev201534473575126361774
- LissoniPBrivioFFumagalliLEfficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumorsInt J Biol Markers200419213514015255546
- LiMXLiuXMZhangXFPrognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysisInt J Cancer2014134102403241324122750
- GaldieroMRBonavitaEBarajonIGarlandaCMantovaniAJaillonSTumor associated macrophages and neutrophils in cancerImmunobiology2013218111402141023891329
- IshiiHTakaharaMNagatoTMonocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15Int J Cancer20121301485821618217
- IshikawaSMiyashitaTInokuchiMPlatelets surrounding primary tumor cells are related to chemoresistanceOncol Rep201636278779427349611
- OrellanaRKatoSEricesRPlatelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cellsBMC Cancer20151529025886038
- SawantACAdhikariPNarraSRSrivatsaSSMillsPKSrivatsaSSNeutrophil to lymphocyte ratio predicts short- and long-term mortality following revascularization therapy for ST elevation myocardial infarctionCardiol J201421550050824142685
- KaramanMBaltaSSeyit AhmetAYThe comparative effects of valsartan and amlodipine on vWf levels and N/L ratio in patients with newly diagnosed hypertensionClin Exp Hypertens201335751652223289969
- MocellinMCCamargoCQNunesEAFiatesGMTrindadeEBA systematic review and meta-analysis of the n-3 polyunsaturated fatty acids effects on inflammatory markers in colorectal cancerClin Nutr201635235936925982417
- MocellinMCPastore e Silva JdeACamargo CdeQFish oil decreases C-reactive protein/albumin ratio improving nutritional prognosis and plasma fatty acid profile in colorectal cancer patientsLipids201348987988823888317